cyclopropanecarboxylic acid has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Huo, X; Li, H; Liang, GB; Luo, L; Meinke, PT; Sutton, D; Tang, W; Wang, H; Wilkinson, H; Yang, X; Zaller, D; Zhou, C | 1 |
| Balan, G; Bauman, J; Bhattacharya, S; Castrodad, M; Healy, DR; Herr, M; Humphries, P; Jennings, S; Kalgutkar, AS; Kapinos, B; Khot, V; Lazarra, K; Li, M; Li, Y; Neagu, C; Oliver, R; Paralkar, VM; Piotrowski, DW; Price, D; Qi, H; Simmons, HA; Southers, J; Wei, L; Zhang, Y | 1 |
2 other study(ies) available for cyclopropanecarboxylic acid and Osteoporosis
| Article | Year |
|---|---|
Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis.
Topics: Administration, Oral; Animals; Benzofurans; Cyclopropanes; Drug Evaluation, Preclinical; Female; Half-Life; Osteoporosis; Parathyroid Hormone; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Structure-Activity Relationship | 2016 |
The discovery of novel calcium sensing receptor negative allosteric modulators.
Topics: Administration, Oral; Allosteric Regulation; Anabolic Agents; Animals; Cell Line; Cyclopropanes; Drug Discovery; Humans; Indans; Microsomes, Liver; Osteoporosis; Phenylpropionates; Rats; Receptors, Calcium-Sensing | 2009 |